Titan Bio-Tech shareholders and shareholding pattern
BSE: 524717Chemicals & PetrochemicalsSmall Cap
Last close ₹325.85down ₹7.87 (2.36%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹333.72, restated for the split or bonus that took effect that day.
52-week range of traded prices to 23 Oct 2026
₹137.12Low, 9 Dec 2025₹444.52High, 7 Apr 2026
- Under BSE's long-term additional surveillance, stage I, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,683 Cr1,287th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 13 Aug 2026
- 49.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 9.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.12%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- 20.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 20.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.02
- Volume, BSEVolume. Shares traded on the last trading day.
- 24,929
Who owns Titan Bio-Tech, filing by filing
Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters55.78%
- Indian institutions0.01%
- Individuals and others44.21%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Indian institutions
- Individuals and others
| Per cent | Dec 2016Filed 16 Jan | Mar 2017Filed 19 Apr | Jun 2017Filed 18 Jul | Dec 2017Filed 17 Jan | Mar 2018Filed 24 Apr | Jun 2018Filed 18 Jul | Sep 2018Filed 20 Oct | Dec 2018Filed 15 Jan | Mar 2019Filed 19 Apr | Jun 2019Filed 31 Jul | Dec 2019Filed 11 Jan | Mar 2020Filed 20 Apr | Jun 2020Filed 14 Jul | Dec 2020Filed 9 Jan | Mar 2021Filed 8 Apr | Jun 2021Filed 7 Jul | Sep 2021Filed 18 Oct | Dec 2021Filed 13 Jan | Mar 2022Filed 6 Apr | Jun 2022Filed 13 Jul | Sep 2022Filed 13 Oct | Dec 2022Filed 9 Jan | Jun 2023Filed 15 Jul | Dec 2023Filed 11 Jan | Jun 2024Filed 9 Jul | Dec 2024Filed 13 Jan | Jun 2025Filed 14 Jul | Sep 2025Filed 7 Feb | Dec 2025Filed 16 Jan | Mar 2026Filed 18 Apr | Jun 2026Filed 14 Jul | Sep 2026Filed 14 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 48.01% | 48.00% | 48.00% | 48.00% | 48.00% | 48.00% | 48.00% | 49.49% | 49.49% | 49.73% | 54.35% | 54.35% | 54.40% | 54.24% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.78% | 55.78% | 55.78% | 55.78% | 55.78% | |
| Indian promoters | 48.01% | 48.00% | 48.00% | 48.00% | 48.00% | 48.00% | 48.00% | 49.49% | 49.49% | 49.73% | 54.35% | 54.35% | 54.40% | 54.24% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.78% | 55.78% | 55.78% | 55.78% | 5.92% |
| Foreign promoters | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 49.86% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 51.99% | 52.00% | 52.00% | 52.00% | 52.00% | 52.00% | 52.00% | 50.51% | 50.51% | 50.27% | 45.65% | 45.65% | 45.60% | 45.76% | 44.12% | 44.12% | 44.12% | 44.12% | 44.12% | 44.12% | 44.12% | 44.12% | 44.12% | 44.12% | 44.12% | 44.12% | 44.12% | 44.22% | 44.22% | 44.22% | 44.22% | 44.22% |
| Shares in issue | 77,38,700 | 77,38,700 | 77,38,700 | 77,38,700 | 77,38,700 | 77,38,700 | 77,38,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 4,13,18,500what Shares in issue, Mar 2026, includes. Split on 20 Feb 2026: each share became 5. Earlier filings count the shares before it. | 4,13,18,500 | 4,13,18,500 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | 3,50,000 | 3,50,000 | 3,50,000 | 3,50,000 | – | – | 36,18,831 | 41,43,831 | 41,43,831 | 41,33,831 | 3,75,000 | 3,75,000 | 3,75,000 | 3,75,000 | 3,75,000 | 3,75,000 | 3,75,000 | 3,75,000 | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Promoters' shares locked in | 3,50,000 | 3,50,000 | 3,50,000 | 3,50,000 | – | – | 24,43,831 | 28,18,831 | 28,18,831 | 28,18,831 | 3,75,000 | 3,75,000 | 3,75,000 | 3,75,000 | 3,75,000 | 3,75,000 | 3,75,000 | 3,75,000 | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Titan Bio-Tech promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Titan Securities Limited, 33.59%. The filing names 2 more members with no shares.Promoter buying and selling
| Holder | ||
|---|---|---|
| Titan Securities LimitedForeign companies and others | 33.59% | 1,38,80,775 |
| Tanita Leasing & Finance LimitedForeign companies and others | 9.49% | 39,22,275 |
| Connoisseur Management Services Private LimitForeign companies and others | 6.78% | 28,00,000 |
| Suresh Chand SinglaIndividuals and Hindu undivided families | 1.28% | 5,28,355 |
| Manju SinglaIndividuals and Hindu undivided families | 0.86% | 3,56,050 |
| Madhu GuptaIndividuals and Hindu undivided families | 0.80% | 3,32,550 |
| Raja SinglaIndividuals and Hindu undivided families | 0.74% | 3,05,500 |
| Supriya SinglaIndividuals and Hindu undivided families | 0.66% | 2,72,465 |
| Udit SinglaIndividuals and Hindu undivided families | 0.61% | 2,50,000 |
| Shivom SinglaIndividuals and Hindu undivided families | 0.43% | 1,77,000 |
| Naresh Kumar SinglaIndividuals and Hindu undivided families | 0.42% | 1,72,550 |
| Naresh Kumar Singla HUFIndividuals and Hindu undivided families | 0.12% | 50,000 |
No promoter shares are reported as pledged.
Largest public holders of Titan Bio-Tech, filing by filing
Per cent, on the same shares as the split above.
| Holder | Mar 2019Filed 19 Apr | Jun 2019Filed 31 Jul | Dec 2019Filed 11 Jan | Mar 2020Filed 20 Apr | Jun 2020Filed 14 Jul | Dec 2020Filed 9 Jan | Mar 2021Filed 8 Apr | Jun 2021Filed 7 Jul | Sep 2021Filed 18 Oct | Dec 2021Filed 13 Jan | Mar 2022Filed 6 Apr | Jun 2022Filed 13 Jul | Sep 2022Filed 13 Oct | Dec 2022Filed 9 Jan | Jun 2023Filed 15 Jul | Dec 2023Filed 11 Jan | Jun 2024Filed 9 Jul | Dec 2024Filed 13 Jan | Jun 2025Filed 14 Jul | Sep 2025Filed 7 Feb | Dec 2025Filed 16 Jan | Mar 2026Filed 18 Apr | Jun 2026Filed 14 Jul | Sep 2026Filed 14 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY MINISTRY OF CORPORATE AFFAIRSInvestor education fund | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 9.37% |
| Manish GoelResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.65% | 1.74% | 2.62% | 2.80% | 2.80% | 2.80% | 2.81% |
| TITAN BIOTECH LIMITED UNCLAIMED SUSPENSE DEMAT ACCOUNTCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.51% | – | 2.30% |
| Investor Education and Protection Fund AuthorInvestor education fund | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 9.51% | – |
| Titan Biotech Limited Unclaimed Suspense DemaCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.36% | – |
| Investor Education and Protection Fund AuthorityInvestor education fund | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 9.24% | 9.63% | 9.58% | – | – |
| Mukesh PanjwaniResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.03% | 1.15% | – | – | – | – | – | – | – |
| Avb Shares Trading Private LimitedOther non-institutions | 16.03% | 16.03% | 14.91% | 14.87% | 14.44% | 4.98% | 1.43% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| White Diamand Enterprises Private LimitedOther non-institutions | – | – | – | – | 1.39% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| White Diamand Media and Advertisment Private LimitedOther non-institutions | – | – | 1.39% | 1.39% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| S. Udit Securities Pvt Ltd.Other non-institutions | 10.42% | 9.95% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.